Epistemix

Overview
News
Infectious Disease Tech?
Product stageSegments
Go-to-Market
?
Software
?

Epistemix is a computational modeling software company that develops simulations to model the spread of infectious diseases and inform policymaking. The company's flagship product is the FRED (Framework for Reconstructing Epidemiological Dynamics) platform, an agent-based modeling system that simulates health changes in populations over time. FRED incorporates local public health data, calibrates simulations to specific local conditions, and uses realistic social dynamics based on local policies and regulations. The platform enables analysts to predict and compare the impacts of interventions like vaccination rates, social distancing policies, and venue capacity restrictions on the spread of diseases like Covid-19 within communities.

Epistemix's modeling services have been utilized by various organizations, including school districts, public health departments, event venues, and sports franchises, to assess the safety of reopening strategies during the Covid-19 pandemic. For instance, the company collaborated with the International Housewares Association to develop mitigation strategies for The Inspired Home Show in March 2022, projecting a transmission risk of less than 0.1% among attendees. Similarly, Epistemix partnered with Convene to ensure the safety of events at their facilities from March to July 2022, forecasting a transmission risk below 0.1%.

Key customers and partnerships

Epistemix has formed partnerships with several organizations to provide data-driven insights and simulations for informing Covid-19 safety protocols. In August 2021, the company partnered with the International Housewares Association to develop mitigation strategies for The Inspired Home Show held in March 2022. Epistemix also collaborated with Convene, a premium meeting and event venue operator, since late 2021 to model the spread of Covid-19 and develop appropriate safety measures for events at Convene facilities from March to July 2022.

Furthermore, Epistemix has worked with school districts across multiple states, including Rhode Island, Pennsylvania, West Virginia, Indiana, Oklahoma, Texas, and California, to model school opening decisions during the pandemic. The company has also partnered with the World Health Organization, tech consulting firm Resultant, and the University of Pittsburgh, leveraging its simulation platform for various use cases related to infectious disease modeling and decision support.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
2730 SIDNEY STREET SUITE 300 Pittsburgh PA USA
Founded year:
2018
Employees:
11-50
IPO status:
Private
Total funding:
USD 10.2 mn
Last Funding:
USD 5.0 mn (Series A; Mar 2024)
Last valuation:
USD 20.0 mn (Mar 2024)
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.